Propagation of toxic proteins (such as Aβ and phosphorylated tau) through synapse and synaptic dysfunction appear to be important contributors to cognitive impairments, and therapies targeting these deficits show the potential to improve cognition in AD [37, 38]. Here, MAPT is linked to Alzheimer disease.